Probably a little, on some skin, and nobody can tell you how much. Worth knowing before you put your vaginal cream on your cheeks.
Estrogen keeps collagen in skin, and collagen production falls when estrogen does1. So the idea of putting estrogen back on the face directly is not silly, and it is not new. The small trials date from the 1990s.
The current wave started in 2024, when Dr. Mary Claire Haver, the American gynaecologist behind The New Menopause, began recommending an estriol face cream. She says she uses it every morning under her makeup for “the skin thinning that comes with estrogen loss”2, and that estrogen “upholds the architecture of your skin”3. The product she recommends on her own site is Alloy’s M42. Estriol is a weaker relative of estradiol. Haver herself describes vaginal creams as alcohol-based and drying on the face by comparison2. Plenty of women have used them anyway.
Her case rests on the biology. Women lose about 30 percent of their skin collagen in the years after menopause, she points out3, and every study that has taken a biopsy finds that estrogen applied to the skin puts collagen back7. Her reasoning is that if the tissue is rebuilding, the visible result follows. And since so little estriol is absorbed, she argues, breast cancer risk can be “taken off the table”3.
Three studies matter.
In 1996, 59 women around menopause used a face cream containing either low-dose estradiol or estriol for six months. Wrinkling and moisture improved, and skin biopsies showed more collagen. Blood estrogen rose slightly in the estradiol group and not at all in the estriol group4.
In a later pilot, 15 women already on hormone therapy added a 0.01% estradiol cream to the face for 16 weeks. Skin thickness and collagen increased; blood levels did not change5.
Then the study that complicates it. In 2008, researchers applied estradiol cream to 70 older adults for two weeks, on the hip, the forearm and the face. On sun-protected hip skin, collagen production roughly tripled in the women. On the sun-damaged forearm and face, it made no significant difference, at any dose6. The authors’ conclusion was that sun exposure changes the skin’s ability to respond to estrogen6.
So: small, short trials say yes; the one that tested face skin against protected skin says the face may be the hardest place for it to work. A 2026 review from the American Academy of Dermatology went through all 14 human studies, from 1987 to 2017, and found the same split across them: sun-protected skin responds, crow’s feet and forearms barely do7.
Why so little research, for a drug this old? Estriol and estradiol are long off patent, and no company funds a large trial it can’t profit from. So the question has been left to small academic studies and, lately, to word-of-mouth.
The vaginal creams are different products at different strengths. Estradiol vaginal cream is 0.01% estradiol, the same concentration used in the trials above. Premarin cream is 0.625 mg of conjugated estrogens per gram, six times that concentration, and a different estrogen. Neither is approved for use on the face, Haver says they are drying there2, and no trial has looked at using the same cream vaginally and on the face at once.
If you are going to do it anyway, use the low-dose estradiol cream rather than Premarin, and tell whoever prescribes your hormone therapy.
No estrogen face cream is an approved drug, and nothing for the face is on BC’s PharmaCare list. The route is a prescription for a compounded estriol cream, usually 0.3%, filled at a compounding pharmacy. Any doctor or nurse practitioner can write it; a menopause clinician is the one to ask about the dose.
Set your expectations by the evidence: if your face has had fifty years of sun, the cream may not do much there. But at a low dose it is a small, low-risk experiment with a real mechanism behind it, which is more than most of what’s sold for the same purpose can say. The risk sits in the dose. Low-dose estriol, on a prescription, is the version worth trying.
This article is general information, not medical advice. The medical professional who sees you in person may reach a different assessment, and their judgement takes precedence.